StockNews.com Initiates Coverage on OncoCyte (NASDAQ:OCX)
StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX – Get Free Report) in a report issued on Sunday. The firm set a “sell” rating on the stock. Several other analysts have also recently issued reports on the company. Stephens restated an “equal weight” rating and set a $4.00 price objective on shares of OncoCyte in […]
StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX – Get Free Report) in a report issued on Sunday. The firm set a “sell” rating on the stock. Several other analysts have also recently issued reports on the company. Stephens restated an “equal weight” rating and set a $4.00 price objective on shares of OncoCyte in […]
